Editors' ChoiceAutism

An epigenetic target for autism

See allHide authors and affiliations

Science Translational Medicine  18 Apr 2018:
Vol. 10, Issue 437, eaat4476
DOI: 10.1126/scitranslmed.aat4476


A transient 3-day course of treatment with a histone deacetylase inhibitor persistently rescues atypical social behavior in a Shank3-deficiency mouse model of autism.

View Full Text

Stay Connected to Science Translational Medicine